Paul Campanelli Insider Trading $PRX PAR PHARMACEUTICAL COMPANIES, INC.
Get free email notifications about insider trading for Paul Campanelli.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paul Campanelli. Paul Campanelli is Chief Executive Officer in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Chief Operating Officer in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, Pres-Generics in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, Pres-Par Pharmaceutical in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, Pres. - Generics in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, Pres. Generic Prod Div in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, Pres.-Generics in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, President-Generics in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP; President - Generics in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Exec VP, Pres Generic Prod Div in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Exec VP, Pres Generics Div in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Exec VP, Pres-Generics Div in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Director in Endo International plc ($ENDP) and Group President, Generics in Endo International plc ($ENDP) and President & CEO in Endo International plc ($ENDP) and President, CEO in Endo International plc ($ENDP) and President, Par Pharmaceutical in Endo International plc ($ENDP).
Paul Campanelli in PAR PHARMACEUTICAL COMPANIES, INC.
Trading Symbol: PRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Paul Campanelli: Chief Executive Officer, Chief Operating Officer, EVP, Pres-Par Pharmaceutical, EVP; President - Generics, EVP, Pres. - Generics, EVP, Pres-Generics, EVP, Pres.-Generics, EVP, President-Generics, EVP, Pres. Generic Prod Div, Exec VP, Pres Generic Prod Div
Holdings: 0 shares
Latest Transaction: Oct 02 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Paul Campanelli in PAR PHARMACEUTICAL COMPANIES, INC.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 26 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres. - Generi ... | Sell | S | 20.30 | 100 | 2,030 | 122,349 | 122.4 K to 122.3 K (-0.08 %) |
Aug 26 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres. - Generi ... | Sell | S | 20.28 | 300 | 6,084 | 122,449 | 122.7 K to 122.4 K (-0.24 %) |
Aug 26 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres. - Generi ... | Sell | S | 20.27 | 1,100 | 22,297 | 122,749 | 123.8 K to 122.7 K (-0.89 %) |
Aug 26 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres. - Generi ... | Sell | S | 20.26 | 300 | 6,078 | 123,849 | 124.1 K to 123.8 K (-0.24 %) |
Aug 26 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres. - Generi ... | Sell | S | 20.25 | 4,869 | 98,597 | 124,149 | 129 K to 124.1 K (-3.77 %) |
Aug 26 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres. - Generi ... | Sell | S | 20.24 | 4,700 | 95,128 | 129,018 | 133.7 K to 129 K (-3.51 %) |
Aug 26 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres. - Generi ... | Sell | S | 20.23 | 700 | 14,161 | 133,418 | 134.1 K to 133.4 K (-0.52 %) |
Aug 26 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres. - Generi ... | Sell | S | 20.21 | 2,300 | 46,483 | 134,418 | 136.7 K to 134.4 K (-1.68 %) |
Aug 26 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres. - Generi ... | Sell | S | 20.20 | 9,660 | 195,132 | 136,718 | 146.4 K to 136.7 K (-6.60 %) |
Mar 24 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Generics | Payment of Exercise | F | 11.19 | 2,200 | 24,618 | 146,378 | 148.6 K to 146.4 K (-1.48 %) |
Jan 14 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Generics | Payment of Exercise | F | 12.59 | 1,107 | 13,937 | 148,578 | 149.7 K to 148.6 K (-0.74 %) |
Jan 12 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres.-Generics | Option Exercise | A | 13.06 | 99,541 | 1,300,005 | 99,541 | |
Jan 12 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres.-Generics | Payment of Exercise | F | 12.83 | 1,789 | 22,953 | 149,595 | 151.4 K to 149.6 K (-1.18 %) |
Jan 12 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres.-Generics | Grant | A | 13.59 | 1,044 | 14,188 | 151,384 | 152.4 K to 151.4 K (-0.68 %) |
Dec 23 2008 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres.-Generics | Payment of Exercise | F | 12.43 | 1,807 | 22,461 | 152,428 | 150.6 K to 152.4 K (+1.20 %) |
Nov 20 2008 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, President-Gene ... | Option Exercise | A | 10.99 | 102,881 | 1,130,662 | 102,881 | |
Nov 20 2008 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, President-Gene ... | Grant | A | 0.00 | 45,496 | 0 | 154,235 | 108.7 K to 154.2 K (+41.84 %) |
Mar 26 2008 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres. Generic ... | Payment of Exercise | F | 18.37 | 2,200 | 40,414 | 108,739 | 110.9 K to 108.7 K (-1.98 %) |
Jan 15 2008 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Exec VP, Pres Gener ... | Grant | A | 0.00 | 36,849 | 0 | 110,579 | 73.7 K to 110.6 K (+49.98 %) |
Oct 03 2007 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Exec VP, Pres-Gener ... | Buy | P | 18.19 | 2,100 | 38,199 | 11,874 | 9.8 K to 11.9 K (+21.49 %) |
Mar 26 2007 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Exec VP, Pres Gener ... | Option Exercise | A | 24.27 | 12,700 | 308,229 | 12,700 | |
Mar 26 2007 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Exec VP, Pres Gener ... | Grant | A | 0.00 | 26,300 | 0 | 54,870 | 28.6 K to 54.9 K (+92.05 %) |